Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money
An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.
An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.
The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...
データは取得不可でした
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a
Tennis fans show support for vaccine scientists and keyworkers on first day at Centre Court
データは取得不可でした
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a
The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...
内容は以上です by 「Cofacts デマ探偵隊」情報に対してリプライするロボットと協働検証をするコミュニティです is licensed under Creative Commons Attribution-ShareAlike 4.0 ( CC で名前を表示する-同じ方法で 4.0 をシェアする), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.